|
1
|
Kansara M, Teng MW, Smyth MJ and Thomas
DM: Translational biology of osteosarcoma. Nat Rev Cancer.
14:722–735. 2014. View
Article : Google Scholar : PubMed/NCBI
|
|
2
|
Yamamoto Y, Kanzaki R, Kanou T, Ose N,
Funaki S, Shintani Y, Minami M, Outani H, Takenaka S, Hamada K, et
al: Long-term outcomes and prognostic factors of pulmonary
metastasectomy for osteosarcoma and soft tissue sarcoma. Int J Clin
Oncol. 24:863–870. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Bishop MW, Janeway KA and Gorlick R:
Future directions in the treatment of osteosarcoma. Curr Opin
Pediatr. 28:26–33. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Gao K, Su Z, Liu H and Liu Y:
Anti-proliferation and anti-metastatic effects of sevoflurane on
human osteosarcoma U2OS and Saos-2 cells. Exp Mol Pathol.
108:121–130. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Xu J, Ding R and Xu Y: Effects of long
non-coding RNA SPRY4-IT1 on osteosarcoma cell biological behavior.
Am J Transl Res. 8:5330–5337. 2016.PubMed/NCBI
|
|
6
|
Kotake Y, Goto T, Naemura M, Inoue Y,
Okamoto H and Tahara K: Long noncoding RNA PANDA positively
regulates proliferation of osteosarcoma cells. Anticancer Res.
37:81–85. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Wen JF, Jiang YQ, Li C, Dai XK, Wu T and
Yin WZ: LncRNA-SARCC sensitizes osteosarcoma to cisplatin through
the miR-143-mediated glycolysis inhibition by targeting Hexokinase
2. Cancer Biomark. 28:231–246. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Fu D, Lu C, Qu X, Li P, Chen K, Shan L and
Zhu X: LncRNA TTN-AS1 regulates osteosarcoma cell apoptosis and
drug resistance via the miR-134-5p/MBTD1 axis. Aging (Albany NY).
11:8374–8385. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zhang YH, Fu J, Zhang ZJ, Ge CC and Yi Y:
LncRNA-LINC00152 down-regulated by miR-376c-3p restricts viability
and promotes apoptosis of colorectal cancer cells. Am J Transl Res.
8:5286–5297. 2016.PubMed/NCBI
|
|
10
|
Barbáchano A, Fernández-Barral A, Pereira
F, Segura MF, Ordóñez-Morán P, Carrillo-de Santa Pau E,
González-Sancho JM, Hanniford D, Martínez N, Costales-Carrera A, et
al: SPROUTY-2 represses the epithelial phenotype of colon carcinoma
cells via upregulation of ZEB1 mediated by ETS1 and
miR-200/miR-150. Oncogene. 35:2991–3003. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kou JT, Ma J, Zhu JQ, Xu WL, Liu Z, Zhang
XX, Xu JM, Li H, Li XL and He Q: LncRNA NEAT1 regulates
proliferation, apoptosis and invasion of liver cancer. Eur Rev Med
Pharmacol Sci. 24:4152–4160. 2020.PubMed/NCBI
|
|
12
|
Zhang X, Yao J, Shi H, Gao B and Zhang L:
LncRNA TINCR/microRNA-107/CD36 regulates cell proliferation and
apoptosis in colorectal cancer via PPAR signaling pathway based on
bioinformatics analysis. Biol Chem. 400:663–675. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Li M, Chen H, Zhao Y, Gao S and Cheng C:
H19 functions as a ceRNA in promoting metastasis through decreasing
miR-200s activity in osteosarcoma. DNA Cell Biol. 35:235–240. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Li S, Pei Y, Wang W, Liu F, Zheng K and
Zhang X: Circular RNA 0001785 regulates the pathogenesis of
osteosarcoma as a ceRNA by sponging miR-1200 to upregulate HOXB2.
Cell Cycle. 18:1281–1291. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Pu M, Chen J, Tao Z, Miao L, Qi X, Wang Y
and Ren J: Regulatory network of miRNA on its target: Coordination
between transcriptional and post-transcriptional regulation of gene
expression. Cell Mol Life Sci. 76:441–451. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Liu B, Li J and Cairns MJ: Identifying
miRNAs, targets and functions. Brief Bioinform. 15:1–19. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Liu H, Su P, Zhi L and Zhao K: miR-34c-3p
acts as a tumor suppressor gene in osteosarcoma by targeting
MARCKS. Mol Med Rep. 15:1204–1210. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zhang M, Wang D, Zhu T and Yin R:
miR-214-5p targets ROCK1 and suppresses proliferation and invasion
of human osteosarcoma cells. Oncol Res. 25:75–81. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zhao B, Song X and Guan H: CircACAP2
promotes breast cancer proliferation and metastasis by targeting
miR-29a/b-3p-COL5A1 axis. Life Sci. 244:1171792020. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wang X, Liu S, Cao L, Zhang T, Yue D, Wang
L, Ping Y, He Q, Zhang C, Wang M, et al: miR-29a-3p suppresses cell
proliferation and migration by downregulating IGF1R in
hepatocellular carcinoma. Oncotarget. 8:86592–86603. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Gado MM, Mousa NO, Badawy MA, El Taweel MA
and Osman A: Assessment of the diagnostic potential of miR-29a-3p
and miR-92a-3p as circulatory biomarkers in acute myeloid leukemia.
Asian Pac J Cancer Prev. 20:3625–3633. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Cai J, Qiao B, Gao N, Lin N and He W: Oral
squamous cell carcinoma-derived exosomes promote M2 subtype
macrophage polarization mediated by exosome-enclosed miR-29a-3p. Am
J Physiol Cell Physiol. 316:C731–C740. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Liang J, Wang S and Wang Z: Role of
microRNAs in embryo implantation. Reprod Biol Endocrinol.
15:902017. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Sui Y, Zhang X, Yang H, Wei W and Wang M:
MicroRNA-133a acts as a tumour suppressor in breast cancer through
targeting LASP1. Oncol Rep. 39:473–482. 2018.PubMed/NCBI
|
|
25
|
Ma X, Zhang H, Yin H, Geng S, Liu Y, Liu
C, Zhao J, Liu Y, Wang X and Wang Y: Up-regulated microRNA-218-5p
ameliorates the damage of dopaminergic neurons in rats with
Parkinson's disease via suppression of LASP1. Brain Res Bull.
166:92–101. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Huang Z, Pang G, Huang YG and Li C:
miR-133 inhibits proliferation and promotes apoptosis by targeting
LASP1 in lupus nephritis. Exp Mol Pathol. 114:1043842020.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zhang X, Liu Y, Fan C, Wang L, Li A, Zhou
H, Cai L, Miao Y, Li Q, Qiu X and Wang E: Lasp1 promotes malignant
phenotype of non-small-cell lung cancer via inducing
phosphorylation of FAK-AKT pathway. Oncotarget. 8:75102–75113.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Yan P, Liu J, Zhou R, Lin C, Wu K, Yang S,
Yang S, Zhou J, Xu L, Wang H and Zhao L: LASP1 interacts with
N-WASP to activate the Arp2/3 complex and facilitate colorectal
cancer metastasis by increasing tumour budding and worsening the
pattern of invasion. Oncogene. 39:5743–5755. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Dimova I, Orsetti B, Negre V, Rouge C,
Ursule L, Lasorsa L, Dimitrov R, Doganov N, Toncheva D and Theillet
C: Genomic markers for ovarian cancer at chromosomes 1, 8 and 17
revealed by array CGH analysis. Tumori. 95:357–366. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Li Z, Chen Y, Wang X, Zhang H, Zhang Y,
Gao Y, Weng M, Wang L, Liang H, Li M, et al: LASP-1 induces
proliferation, metastasis and cell cycle arrest at the G2/M phase
in gallbladder cancer by down-regulating S100P via the PI3K/AKT
pathway. Cancer Lett. 372:239–250. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Shen Y, Yang Y and Li Y: MiR-133a acts as
a tumor suppressor in lung cancer progression by regulating the
LASP1 and TGF-β/Smad3 signaling pathway. Thorac Cancer.
11:3473–3481. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Yin L, Chen Y, Zhou Y, Deng G, Han Y, Guo
C, Li Y, Zeng S and Shen H: Increased long noncoding RNA LASP1-AS
is critical for hepatocellular carcinoma tumorigenesis via
upregulating LASP1. J Cell Physiol. 234:13493–13509. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Meister P, Konrad E, Lob G, Janka G, Keyl
W and Stürz H: Osteosarcoma: Histological evaluation and grading.
Arch Orthop Trauma Surg. 94:91–98. 1979. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Du Y, Wei N, Hong J and Pan W: Long
non-coding RNASNHG17 promotes the progression of breast cancer by
sponging miR-124-3p. Cancer Cell Int. 20:402020. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Jia P, Cai H, Liu X, Chen J, Ma J, Wang P,
Liu Y, Zheng J and Xue Y: Long non-coding RNA H19 regulates glioma
angiogenesis and the biological behavior of glioma-associated
endothelial cells by inhibiting microRNA-29a. Cancer Lett.
381:359–369. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Hu Z, Cui Y, Zhou Y, Zhou K, Qiao X, Li C
and Wang S: MicroRNA-29a plays a suppressive role in non-small cell
lung cancer cells via targeting LASP1. Onco Targets Ther.
9:6999–7009. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Moore DD and Luu HH: Osteosarcoma. Cancer
Treat Res. 162:65–92. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Sleijfer S, Rizzo E, Litière S, Mathijssen
RHJ, Judson IR, Gelderblom H, Van Der Graaf WTA and Gronchi A:
Predictors for doxorubicin-induced hematological toxicity and its
association with outcome in advanced soft tissue sarcoma patients;
a retrospective analysis of the EORTC-soft tissue and bone sarcoma
group database. Acta Oncol. 57:1117–1126. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Wang D, Wang D, Wang N, Long Z and Ren X:
Long non-coding RNA BANCR promotes endometrial cancer cell
proliferation and invasion by regulating MMP2 and MMP1 via ERK/MAPK
signaling pathway. Cell Physiol Biochem. 40:644–656. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
He P, Zhang Z, Huang G, Wang H, Xu D, Liao
W and Kang Y: miR-141 modulates osteoblastic cell proliferation by
regulating the target gene of lncRNA H19 and lncRNA H19-derived
miR-675. Am J Transl Res. 8:1780–1788. 2016.PubMed/NCBI
|
|
42
|
Liu C, Pan C, Cai Y and Wang H: Interplay
between long noncoding RNA ZEB1-AS1 and miR-200s regulates
osteosarcoma cell proliferation and migration. J Cell Biochem.
118:2250–2260. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Orth MF, Cazes A, Butt E and Grunewald TG:
An update on the LIM and SH3 domain protein 1 (LASP1): A versatile
structural, signaling, and biomarker protein. Oncotarget. 6:26–42.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Wang LL, Wang L, Wang XY, Shang D, Yin SJ,
Sun LL and Ji HB: MicroRNA-218 inhibits the proliferation,
migration, and invasion and promotes apoptosis of gastric cancer
cells by targeting LASP1. Tumour Biol. 37:15241–15252. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Gebeshuber CA, Zatloukal K and Martinez J:
miR-29a suppresses tristetraprolin, which is a regulator of
epithelial polarity and metastasis. EMBO Rep. 10:400–405. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Yu L, Liu S, Guo W, Zhang C, Zhang B, Yan
H and Wu Z: hTERT promoter activity identifies osteosarcoma cells
with increased EMT characteristics. Oncol Lett. 7:239–244. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Liu X, Fan Y, Xie J, Zhang L, Li L and
Wang Z: Dehydroandrographolide inhibits osteosarcoma cell growth
and metastasis by targeting SATB2-mediated EMT. Anticancer Agents
Med Chem. 19:1728–1736. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Casola S, Pedone PV, Cavazzana AO, Basso
G, Luksch R, d'Amore ES, Carli M, Bruni CB and Riccio A: Expression
and parental imprinting of the H19 gene in human rhabdomyosarcoma.
Oncogene. 14:1503–1510. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Wang L, Cai Y, Zhao X, Jia X, Zhang J, Liu
J, Zhen H, Wang T, Tang X, Liu Y and Wang J: Down-regulated long
non-coding RNA H19 inhibits carcinogenesis of renal cell carcinoma.
Neoplasma. 62:412–418. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Chan LH, Wang W, Yeung W, Deng Y, Yuan P
and Mak KK: Hedgehog signaling induces osteosarcoma development
through Yap1 and H19 overexpression. Oncogene. 33:4857–4866. 2014.
View Article : Google Scholar : PubMed/NCBI
|
